Eli Lilly's Zepbound Weight Loss Drug No Longer in Shortage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled “Hacking America's Health Care: Assessing Cyberattack's…
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
A merged image shows an injectable pen of Zepbound, Eli Lilly's weight-loss drug, and boxes of Wegovy, made by Novo…
We are buying 300 shares of Bristol-Myers Squibb at approximately $58 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will…
A merged image shows an injectable pen of Zepbound, Eli Lilly's weight-loss drug, and boxes of Wegovy, made by Novo…
The new trial data has cemented Club's lead position behind Eli Lilly in the highly competitive anti-obesity drug race. Eli…
In this photo illustration, a McDonald's Quarter Pounder burger is seen at a McDonald's on October 23, 2024 in the…
Omar Marqués | Light rocket | fake images Actions of amgen fell more than 7% on Tuesday as analysts analyzed…
Jakub Porzycki | Nurfoto | fake images Novo Nordisk on Wednesday reported a beat in third-quarter sales of its blockbuster…